Can a common drug mend a broken heart? new trial aims to find out
NCT ID NCT05946772
First seen May 02, 2026 · Last updated Jun 09, 2026 · Updated 8 times
Summary
This study tests if the drug cyclosporine can reduce heart muscle damage in people with Takotsubo syndrome, also known as broken heart syndrome. About 204 adults at high risk for complications will receive either cyclosporine or a placebo shortly after diagnosis. Researchers will measure heart injury and function over a year to see if the drug helps the heart recover better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TAKOTSUBO CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cardiovascular Centre - University Hospital Düsseldorf
RECRUITINGDüsseldorf, Germany
Contact
-
Department of Cardiology - University Hospital Essen
RECRUITINGEssen, Germany
Contact
-
Department of Cardiology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin
RECRUITINGBerlin, Germany
Contact
-
Department of Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
RECRUITINGBerlin, Germany
Contact
Contact
-
Department of Cardiology, Heidelberg University Hospital
RECRUITINGHeidelberg, 69120, Germany
Contact
Contact
Contact
-
Department of Cardiology, Hospital of the Ludwig-Maximilians-University Munich
RECRUITINGMünchen, Germany
Contact
-
Department of Cardiology, University Hospital Dresden
RECRUITINGDresden, Germany
Contact
-
Department of Cardiology, University Hospital Frankfurt
RECRUITINGFrankfurt, Germany
Contact
-
Department of Cardiology, University Hospital Halle
RECRUITINGHalle, Germany
Contact
-
Department of Cardiology, University Hospital Köln
RECRUITINGCologne, Germany
Contact
-
Department of Cardiology, University Hospital Leipzig
RECRUITINGLeipzig, Germany
Contact
-
Department of Cardiology, University Hospital Magdeburg
RECRUITINGMagdeburg, Germany
Contact
-
Department of Cardiology, University Hospital Mainz
RECRUITINGMainz, Germany
Contact
Contact
Contact
-
Department of Cardiology, University Hospital Mannheim
RECRUITINGMannheim, Germany
Contact
-
Department of Cardiology, University Hospital Rostock
RECRUITINGRostock, Germany
Contact
-
Department of Cardiology, University Hospital Ulm
RECRUITINGUlm, Germany
Contact
-
Department of Cardiology, University Hospital Wuppertal
RECRUITINGWuppertal, Germany
Contact
-
Heart Centre - University Hospital Bonn
RECRUITINGBonn, Germany
Contact
Contact
-
Kerckhoff Heart Center, Bad Nauheim / Gießen University
RECRUITINGBad Nauheim, Germany
Contact
-
Leipzig Heart Center
RECRUITINGLeipzig, Germany
Contact
-
University Hospital rechts der Isar, Technical University of Munich
RECRUITINGMünchen, Germany
Contact
Contact
-
University Medical Center Göttingen
RECRUITINGGöttingen, Germany
Contact
-
University Medical Center Hamburg-Eppendorf
RECRUITINGHamburg, Germany
Contact
-
University Medical Center Schleswig-Holstein/Campus Lübeck
RECRUITINGLübeck, Germany
Contact
Conditions
Explore the condition pages connected to this study.